QCM
TAK icon

Quantinno Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Quantinno Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
1,402,650
+113,324
+9% +$1.88M 0.03% 676
2026
Q1 		$23.9M Buy
1,289,326
+219,999
+21% +$3.86M 0.04% 545
2025
Q4 		$16.7M Buy
1,069,327
+95,472
+10% +$1.36M 0.03% 583
2025
Q3 		$14.3M Buy
973,855
+176,819
+22% +$2.63M 0.04% 520
2025
Q2 		$12.3M Buy
797,036
+280,992
+54% +$4.15M 0.05% 425
2025
Q1 		$7.67M Buy
516,044
+34,211
+7% +$479K 0.05% 477
2024
Q4 		$6.38M Buy
481,833
+120,120
+33% +$1.65M 0.06% 384
2024
Q3 		$5.14M Buy
361,713
+10,258
+3% +$146K 0.07% 345
2024
Q2 		$4.55M Buy
351,455
+104,386
+42% +$1.38M 0.08% 272
2024
Q1 		$3.43M Buy
247,069
+104,547
+73% +$1.52M 0.07% 312
2023
Q4 		$2.03M Sell
142,522
-2,846
-2% -$40.4K 0.07% 360
2023
Q3 		$2.25M Buy
145,368
+69,297
+91% +$1.07M 0.1% 259
2023
Q2 		$1.2M Buy
76,071
+10,801
+17% +$177K 0.07% 374
2023
Q1 		$1.08M Buy
65,270
+21,948
+51% +$350K 0.07% 357
2022
Q4 		$676K Buy
+43,322
New +$605K 0.05% 448

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Quantinno Capital Management's TAK Position: Q2 2026 in Review

Quantinno Capital Management increased its Takeda Pharmaceutical (TAK) stake by 8.8% in Q2 2026, buying an estimated $1.88M and bringing the position to 1,402,650 shares worth $22.5M. The position accounts for 0.03% of the portfolio, ranked #676.

Quantinno Capital Management first reported a position in TAK in Q4 2022 and has held it in 15 quarters since. The position peaked at $23.9M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Quantinno Capital Management held 1,402,650 shares of Takeda Pharmaceutical worth $22.5M as of Q2 2026.
  • Quantinno Capital Management bought 113,324 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.88M.
  • Takeda Pharmaceutical made up 0.03% of Quantinno Capital Management's portfolio in Q2 2026, its #676 holding.
  • Quantinno Capital Management first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Quantinno Capital Management's Takeda Pharmaceutical position peaked at $23.9M in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.